Experiences with
Cyclophosphamide1,139 public posts
Want to take advantage of all our features? Just log in!
or
Question - how many different varieties of antibodies can B-cells make? Hint - it's hypermutation (IGHV mutation) that makes it possible
Answer, 1 quintillion or 1,000,000,000,000,000,000 or 10^18 according to[i] a team led by Drs. Bryan Briney and Dennis R. Burton at Scripps Research examined antibody-producing B cells isolated from blood samples of 10 people between the ages of 18 and 30. ... Additional studies are needed to more accurately
Treatments for C3G
These drugs include:
o Glucocorticoids (corticosteroids, steroids)
o Rituximab
o Cyclophosphamide
o Mycophenolate mofetil (MMF)
o Tacrolimus
o Sirolimus
o Azathioprine
• Plasma exchange (plasmapheresis): Plasma
Benlysta Maintenance Does Not Change Kidney Function of Lupus Nephritis Patients, Phase 2 Trial Shows
All participants received 1,000 mg of intravenous (into the bloodstream) Rituxan, 750 mg of the immunosuppressive therapy cyclophosphamide, and 200 mg of the corticosteroid methylprednisolone at the start of the study and the second week, and an initial daily prednisone dose of 40 mg, which was progressively
ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR
Hi friends,
The early buzz at ASH 2018 was rightly about the ECOG trial that was presented on the last day as a late breaking abstract.
In my interview at the opening of the conference, Dr. Stilgenbauer discusses the practice changing significance of this study that proved that ibrutinib and rituximab
FCR, novel agents, advances in CLL treatment, what CLL patients can hope for in the future. Australian experts discuss advances at ASH2018
Great to hear of real change beginning to happen in CLL, we really do have a reason to be hopeful. Leukaemia Care have interviewed global experts at The American Society of Haematology conference (ASH) on video for you to share in this.
https://youtu.be/vLleI7G-gfk
https://youtu.be/lEz4GkRX3Q8
https